Inhibitor Therapeutics, Inc. (INTI)
OTCMKTS · Delayed Price · Currency is USD
0.1000
+0.0020 (2.04%)
Oct 16, 2026, 4:00 PM EST
Inhibitor Therapeutics Market Cap
Inhibitor Therapeutics has a market cap or net worth of $17.38 million as of October 19, 2026. It is the 37,384th most valuable company in the world and the 5,238th biggest in the United States. Its market cap has increased by 110.51% in one year.
Market Cap
17.38M
Enterprise Value
16.91M
Revenue
n/a
Global Rank
Country Rank
#5,238 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since October 29, 1997, Inhibitor Therapeutics's market cap has increased from 14.08M to 17.38M, an increase of 23.47%. That is a compound annual growth rate of 0.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 19.10M | 145.95% |
| Dec 31, 2025 | 7.77M | -25.02% |
| Dec 31, 2024 | 10.36M | -34.56% |
| Dec 28, 2023 | 15.83M | -57.47% |
| Dec 28, 2022 | 37.21M | -34.06% |
| Dec 30, 2021 | 56.43M | 332.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biomind Labs | 35.68M |
| Cell Source | 33.63M |
| ZIVO Bioscience | 26.99M |
| Aeternum Resources | 26.87M |
| Provectus Biopharmaceuticals | 20.47M |
| HST Global | 18.91M |
| Vicapsys Life Sciences | 12.95M |
| America Great Health | 12.69M |